Synthesis, docking studies and antitumor activity of phenanthroimidazole derivatives as promising c-myc G-quadruplex DNA stabilizers
Qiong Wu,Yue Song,Ruotong Liu,Rui Wang,Wenjie Mei,Weiming Chen,Huanglan Yang,Xicheng Wang
DOI: https://doi.org/10.1016/j.bioorg.2020.104074
IF: 5.307
2020-09-01
Bioorganic Chemistry
Abstract:<p>Phenanthroimidazole derivatives containing phenanthroline and imidazole heterocyclic aromatic rings are effective agents to inhibit tumor cell growth. Herein, halogen element-modified imidazo[4,5<em>f</em>][1,10]phenanthroline derivatives <strong>1–6</strong> (<strong>1</strong>, 4-fluorophenyl; <strong>2</strong>, 4-chlorophenyl; <strong>3</strong>, 4-bromobenyl; <strong>4</strong>, 2,3-dichlorophenyl; <strong>5</strong>, 3,4-dichlorophenyl; and <strong>6</strong>, 2,4-dichlorophenyl) were synthesized, and their antitumor activities were investigated. All of the compounds, especially <strong>4</strong>, exhibited an excellent inhibitory effect against nasopharyngeal carcinoma CNE-1 cells. This effect was better than that of doxorubicin. Compound <strong>4</strong> also markedly blocked the proliferation of the CNE-1 cells in a zebrafish xenograft model. The antitumor mechanisms might be attributed to apoptosis induction, which triggered ROS-mediated DNA damage and generated mitochondrial dysfunction by stabilizing c-myc G-quadruplex DNA structure. Results indicated that phenanthroimidazole derivatives could act as promising anticancer agents.</p>
biochemistry & molecular biology,chemistry, organic